| Nicole Marie Durie, MD | |
|
290 Big Run Rd, Lexington, KY 40503-2903 | |
| (859) 278-9513 | |
| (859) 277-6063 |
| Full Name | Nicole Marie Durie |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 290 Big Run Rd, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518298413 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unity Hospital | Rochester, NY | Hospital |
| United Memorial Medical Center | Batavia, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Unity Hospital Of Rochester | 9436060969 | 517 |
| Chipps, Caffrey And Dubilier, P.s.c | 4688573900 | 22 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Newark Wayne Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770671182 PECOS PAC ID: 0446154199 Enrollment ID: O20031212000722 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | The Unity Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760421713 PECOS PAC ID: 9436060969 Enrollment ID: O20031230000038 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Orleans Community Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609873520 PECOS PAC ID: 7315857018 Enrollment ID: O20040504000620 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | United Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902800352 PECOS PAC ID: 0547259376 Enrollment ID: O20040507000847 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Clifton Springs Sanitarium Co |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366505463 PECOS PAC ID: 5092704809 Enrollment ID: O20040525000569 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124486329 PECOS PAC ID: 1759293111 Enrollment ID: O20160413000300 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Marie Durie, MD 290 Big Run Rd, Lexington, KY 40503-2903 Ph: (859) 278-9513 | Nicole Marie Durie, MD 290 Big Run Rd, Lexington, KY 40503-2903 Ph: (859) 278-9513 |
News Archive
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.
Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.
› Verified 1 days ago
Dr. Kirk Phillip Heitman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Ms117, Lexington, KY 40536 Phone: 859-257-1446 | |
Alexander Patrick Smith, Pathology Medicare: Medicare Enrolled Practice Location: 290 Big Run Rd, Lexington, KY 40503 Phone: 859-278-9513 | |
Dr. Amy Siegel Gewirtz, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St # Ms 117, Lexington, KY 40536 Phone: 859-323-5425 | |
Therese Jeanne Bocklage, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St # Ms 117, Lexington, KY 40536 Phone: 859-323-5425 | |
Dr. Paul Bachner, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 800 Rose Street, Lexington, KY 40536 Phone: 859-323-5425 | |
Dr. Peter Tobias Nelson, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 800 Rose St # Ms 117, Lexington, KY 40536 Phone: 859-323-5425 | |
Dr. James L Bauer, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 290 Big Run Rd, Lexington, KY 40503 Phone: 859-278-9513 Fax: 859-277-6063 |